Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Langley

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|May 1, 1984
Normal T cell colony numbers in untreated patients with chronic lymphocytic leukaemia (CLL)L A Fernandez, J M MacSween, G R Langley
Immunology|February 1, 1975
Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemiaL A Fernandez, J M MacSween, G R Langley
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 1, 1992
Effect of nonmedical factors on family physicians' decisions about referral for consultationG R Langley, A M MacLellan, H J Sutherland, et al.
Journal of Clinical Epidemiology|January 1, 1991
Use of written cases to study factors associated with regional variations in referral ratesG R Langley, D L Tritchler, H A Llewellyn-Thomas, et al.
Canadian Medical Association Journal|December 4, 1976
Cytotoxic lymphocytes in infectious mononucleosisD C Osborn, R A Fox, L A Fernandez, et al.
British Journal of Haematology|February 1, 1980
Characterization of null cells in chronic lymphocytic leukaemia with B-cell allo- and hetero-antiseraS M Kirov, W O Kwant, L A Fernandez, et al.
Leukemia & Lymphoma|July 28, 2016
Outcome of Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma Referred for Autologous Bone Marrow TransplantationJ M Brandwein, A M Smith, G R Langley, et al.
Controlled Clinical Trials|March 1, 1987
Why are (or are not) patients given the option to enter clinical trials?G R Langley, H J Sutherland, S Wong, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Demonstration of differences in drug resistance by direct testing of DNA excision repair activity following standard and liposomal daunorubicin exposure in normal paediatric marrow using high resolution CLSMC L Lannon, L M Ball, A F Pyesmany, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Differential kinetics of drug resistance in human leukaemic cells measured by SCGE/CLSML M Ball, C L Lannon, G R Langley, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|May 1, 1984
Normal T cell colony numbers in untreated patients with chronic lymphocytic leukaemia (CLL)L A Fernandez, J M MacSween, G R Langley
Immunology|February 1, 1975
Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemiaL A Fernandez, J M MacSween, G R Langley
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 1, 1992
Effect of nonmedical factors on family physicians' decisions about referral for consultationG R Langley, A M MacLellan, H J Sutherland, et al.
Journal of Clinical Epidemiology|January 1, 1991
Use of written cases to study factors associated with regional variations in referral ratesG R Langley, D L Tritchler, H A Llewellyn-Thomas, et al.
Canadian Medical Association Journal|December 4, 1976
Cytotoxic lymphocytes in infectious mononucleosisD C Osborn, R A Fox, L A Fernandez, et al.
British Journal of Haematology|February 1, 1980
Characterization of null cells in chronic lymphocytic leukaemia with B-cell allo- and hetero-antiseraS M Kirov, W O Kwant, L A Fernandez, et al.
Leukemia & Lymphoma|July 28, 2016
Outcome of Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma Referred for Autologous Bone Marrow TransplantationJ M Brandwein, A M Smith, G R Langley, et al.
Controlled Clinical Trials|March 1, 1987
Why are (or are not) patients given the option to enter clinical trials?G R Langley, H J Sutherland, S Wong, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Demonstration of differences in drug resistance by direct testing of DNA excision repair activity following standard and liposomal daunorubicin exposure in normal paediatric marrow using high resolution CLSMC L Lannon, L M Ball, A F Pyesmany, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Differential kinetics of drug resistance in human leukaemic cells measured by SCGE/CLSML M Ball, C L Lannon, G R Langley, et al.
Pageof 3